Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22402037 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Vaccine Therapy in Preventing Cytomegalovirus in Healthy Participants
Condition: Nonneoplastic Condition
Interventions: Biological: PADRE-CMV fusion peptide vaccine;   Biological: tetanus-CMV fusion peptide vaccine;   Drug: agatolimod sodium

Study has passed its completion date and status has not been verified in more than two years.